Investing.com - Decibel Therapeutics reported on Thursday third quarter earnings that beat analysts' forecasts and revenue that was inline with expectations.
Decibel Therapeutics announced earnings per share of $-0.640 on revenue of $0.00. Analysts polled by Investing.com EPS of $-0.667 on revenue of $0.00.
Decibel Therapeutics 's are down 16.92% and is trading at $3.240 , still down 58.30% from its 52 week high of $7.77 set on Tuesday, November 16, 2021.
Decibel Therapeutics shares gained 4.18% to trade at $3.240 in intra-day trade the report.
Decibel Therapeutics follows other major Healthcare sector earnings this month
Decibel Therapeutics's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.89B, EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar